Acasti Pharma to Report Third Quarter 2023 Financial Results on Tuesday, February 14, 2023PRNewsWire • 02/07/23
Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price RuleGlobeNewsWire • 01/25/23
Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31GlobeNewsWire • 01/24/23
Acasti Pharma Discusses Positive Clinical Study Results for GTX-101 and GTX-102 and Upcoming Phase 3 Study for GTX-104 with The Stock Day PodcastNewsfile Corp • 01/17/23
Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome MeasuresGlobeNewsWire • 01/05/23
Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company's Drug Candidate for the Treatment of Ataxia TelangiectasiaGlobeNewsWire • 12/28/22
Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022GlobeNewsWire • 11/07/22
Acasti Announces Voting Results from 2022 Annual and Special Meeting of ShareholdersGlobeNewsWire • 09/29/22
Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day PodcastNewsfile Corp • 09/21/22
Acasti Pharma to Participate in the Lytham Partners Fall 2022 Investor ConferenceGlobeNewsWire • 09/14/22
Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-102, the Company's Drug Candidate for the Treatment of Ataxia TelangiectasiaGlobeNewsWire • 09/13/22
Acasti Pharma to Participate at the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/12/22
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q1 2023 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022GlobeNewsWire • 08/02/22
Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day PodcastNewsfile Corp • 07/07/22
Acasti Pharma, Inc. (ACST) CEO Jan D'Alvise on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha • 06/21/22